- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05879731
Consciousness and Nociception During Anesthesia (NOCICON)
Characterizing the Effect of Nociception on Whole-brain Functional Connectivity Markers of Consciousness During General Anesthesia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Until now, the clinical neuromonitoring of consciousness in general anesthesia has relied on the electrophysiological assessment of isolated frontal regions of the brain, providing only partial insight into the neural mechanisms involved in sustaining or suspending consciousness. What is more, functional connectivity and graph theory markers of consciousness have not yet been investigated in response to nociception during surgical anesthesia, and it remains unclear how nociception affects anesthetic-induced unconsciousness.
Aims: This study will investigate how hd-EEG (high density electroencephalogram) functional markers of consciousness are associated to nociception during general anesthesia. More specifically, the aim of this study is to characterize whole-brain functional connectivity and network changes induced by noxious stimulation, and adapt these findings to a clinically-applicable EEG (electroencephalogram) montage. To this end, three specific objectives have been set:
- Compare the functional connectivity and network characteristics of general anesthesia before, during and after tetanic stimulation of the ulnar nerve during general anesthesia
- Investigate the association between functional connectivity and network properties and the changes in hypnotic depth and nociception calculated by standard clinical neuromonitoring tools.
- Identify the combination of 20 EEG channels that optimally detect changes in the functional network induced by noxious stimulation.
Study design: This study will be a preliminary prospective and observational study. It will be conducted on thirty patients (n = 30) scheduled for surgery under general anesthesia. Patients will be recruited and tested from Hôpital Maisonneuve-Rosemont, with the hd-EEG (high density electroencephalogram) system of the Center for Advanced Research in Sleep Medicine (CARSM) of the Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS-NIM).
Protocol: No premedication will be administered. When entering the operating room, the investigators will place a 128-channel EEG saline net (MagstimEGI) referenced to Cz on the patient's head (10 min application time). Impedances will be verified and maintained <50 kΩ for the duration of the study. The patient will be positioned supine and all routine monitors will be installed (electrocardiography, non-invasive blood pressure and pulse oximetry, nasopharyngeal temperature and end-tidal partial pressure of carbon dioxide). The PMD200TM monitor (a finger sensor device which reflects low to high nociception) as well as the Bispectral Index (BIS), will be connected to the anesthesia machine and the patient, recording the Nociception Level (NOL) index and BIS continuously.
A 5-min baseline resting-state EEG with eyes closed will be performed before induction (Awake). Baseline values of NOL, BIS, mean arterial pressure (MAP) and heart rate (HR) will be recorded for 1 min before induction.General anesthesia will be induced with propofol and remifentanil. Propofol will be administered with a target-controlled infusion (TCI) pump, using the Marsh pharmacokinetic model,46 with initial target predicted effect-site concentration of propofol at 2.0 mcg/ml in flash mode. Propofol targets will be adjusted by increments of 0.2 mcg/ml until a BIS between 45-55 is reached. Simultaneously, remifentanil will be administered for induction of anesthesia at the dose of 1 mcg.Kg-1 over 30 sec, with a targeted NOL index below a threshold of 10. To eliminate potential electromyographical contamination of BIS and EEG, rocuronium (0.8 mg/kg bolus followed by infusion) will be given once the patient is no longer responding and a BIS 45-55 is achieved. The patient will be then manually ventilated with 100% inspired O2 until the response to electrical stimulation of the forearm shows that muscle relaxants are fully active. The patient will be intubated with a video laryngoscope and a stylet and mechanical ventilation will be initiated. Hypnotic depth will be continuously monitored with a BIS value between 45 and 55, and propofol administration will be adjusted to maintain this target. Remifentanil will be paused once no more painful stimulation occurs.
At this point, noxious stimulation will be delayed at least 10 minutes after remifentanil is paused to allow for the remifentanil to be cleared out. During this period, time will be judiciously used to position the patient, apply sterile drape and prepare surgical equipment. Finally, a "no pain period" of 5 min, during which the patient faces no stimulation or manipulation, will take place. During this 5-min Pre-Stimulation period, resting-state EEG recording will be recorded. Measurements of the NOL Index, BIS, HR and MAP will start 1 min before applying noxious stimulus (means will constitute the basal values for NOL and HR for the Pre-Stimulation condition).
Electric stimulation will then be applied. This will consist in a standardized tetanic stimulation to the ulnar nerve of the non-dominant forearm delivered by a routine nerve stimulator (100 Hz, 70 mA) for a duration of 30 sec.47 Hd-EEG recording and simultaneous measurements of the NOL Index, BIS, HR and MAP will take place during the 30 sec of tetanic stimulation (Stimulation), and will continue during the 5 min after (Post-Stimulation). This window of recording will be kept free of any other external stimulation. Once this period over, the EEG net will be removed and the investigators will exit the operating room. Surgery will begin and anesthetic procedures will continue as standard of care.
Data analyses: Data analyses will be led at CIUSSS-NIM. Hd-EEG data will be bandpass filtered from 0.1 to 50 Hz, and non-scalp channels will be discarded. Noisy epochs and channels, muscle and non-physiological artifacts will be removed. EEG data will be re-referenced to an average reference. For each patient-condition, the investigators will construct functional connectivity networks using the amplitude envelope correlation (AEC), weighted phase lag index (wPLI)48 and directed phase lag index (dPLI),49 in delta (0.5-4Hz), theta (4-7 Hz), alpha (8-13 Hz) and beta (14-30 Hz) frequency bands for all pairwise combinations of electrode channels on 10-sec windows. From AEC and wPLI networks, the investigators will calculate graph theoretical properties (e.g. binary small-worldness, clustering coefficient, modularity, global efficiency) to appraise overall functional integration and differentiation. dPLI matrices will be used to assess degree and direction of frontoparietal connectivity across conditions. Variations in the BIS (delta-BIS) and NOL (delta-NOL) across conditions, as well as the peak value of the NOL (peak-NOL) during the Stimulation and Post-Stimulation conditions will be recorded.
Statistical analyses: The investigators will compare the Awake, Pre-Stimulation, Stimulation and Post-Stimulation conditions on the various functional connectivity and network properties using independent-samples t-tests and ANOVA with age and sex as covariates, in order to appraise differences across conditions. The investigators will then use k-means clustering analysis to identify the measures most capable of distinguishing conditions with and without noxious simulation. The most salient features identified using k-means will then be correlated with the induced delta-BIS and delta-NOL, and peak-NOL, to investigate the relationship between these variables. Finally, the investigators will use a deep machine learning approach to identify the combination of 20 EEG channels that can most strongly detect pain-induced alterations in the functional connectivity and network properties. P-values will be corrected for multiple comparisons with familywise error correction. If the chosen functional connectivity and network markers do not yield statistical differences in response to noxious stimulation in SA1, the investigators will proceed to a deep machine learning approach with feature learning, using convolution architecture, in order to identify the EEG features (spectral, temporal and spatial) that show strongest alterations in response to noxious stimulation.
Risks and inconveniences : There are no risks anticipated with participation in this study. The inconvenience associated to electrode placement are minimal, and include potential irritation of the scalp, which disappears on its own. No experimental drugs will be used
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Catherine Duclos, Ph.D
- Phone Number: 5833280 514-338-2222
- Email: catherine.duclos@umontreal.ca
Study Contact Backup
- Name: Naomie Lussier, B.Sc
- Phone Number: 819-437-7934
- Email: naomie.lussier@umontreal.ca
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H1T2M4
- Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal
-
Principal Investigator:
- Catherine Duclos, Ph.D
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18-60 years old
- French or English language comprehension
- ASA score I or II (American Society of Anesthesiologists (ASA) Physical Status Classification System)
Exclusion Criteria:
- Unstable coronary pathology
- Heart rhythm disorder
- Emergency surgery
- Pregnancy
- Preoperative hemodynamic failure
- Drug or alcohol dependence in the last 6 months
- Chronic psychotropic drug use for more than 3 months
- Opioid use in the last 6 weeks or chronic pain conditions
- Psychiatric pathologies
- Allergy to one of the study products
- Difficult intubation
- Unexpected preoperative complication
- Epilepsy
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Participants
Potential participants for the study will be approached by phone on the day prior to their surgery. Details of the study will be explained to the potential participant by a member of the study team, who will also verify inclusion/exclusion criteria. The morning of the surgery, co-investigators will meet the patients to address any concerns. Written informed consent will be obtained by a member of the study team who is not a member of the patient's treating team. Participants will then receive the interventions described in the ''Interventions'' section. |
Once in the operating room, the investigators will place a 128-channel Hd-EEG (high density electroencephalogram) saline net referenced to Cz on the patient's head.
Impedances will be verified and maintained <50 kΩ for the duration of the study.
The patient will be positioned supine and all routine monitors will be installed.
A 5 minutes baseline resting-state Hd-EEG with eyes closed will be performed before induction.
Once under general anesthesia and intubated, a "no pain period" of 5 minutes will take place.
During this 5-min period, resting-state Hd-EEG recording will be recorded.
A standardized tetanic stimulation to the ulnar nerve of the non-dominant forearm delivered by a routine nerve stimulator (100 Hz, 70 mA) for a duration of 30 seconds will then be applied.
Hd-EEG recording will take place during this 30 seconds and will continue during the 5 minutes after.
Once this period will be over, the Hd-EEG net will be removed and the investigators will exit the operating room.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Awake (Baseline resting-state)
Time Frame: 5 minutes
|
EEG with eyes closed will be performed before induction, with a 128-channel EEG saline net (measured in microvolts - mV). Investigators will construct functional connectivity networks using the amplitude envelope correlation (AEC), weighted phase lag index (wPLI) and directed phase lag index (dPLI). This will be conducted in delta (0.5-4Hz), theta (4-7 Hz), alpha (8-13 Hz) and beta (14-30 Hz) frequency bands for all pairwise combinations of electrode channels on 10-sec windows. From wPLI and AEC matrices, investigators will calculate:
dPLI will be used to assess feedback dominance index. Investigators will also calculate:
|
5 minutes
|
Pre-Stimulation (Resting-state)
Time Frame: 5 minutes
|
EEG will be performed after induction, with a 128-channel EEG saline net (measured in microvolts - mV). Investigators will construct functional connectivity networks using the amplitude envelope correlation (AEC), weighted phase lag index (wPLI) and directed phase lag index (dPLI). This will be conducted in delta (0.5-4Hz), theta (4-7 Hz), alpha (8-13 Hz) and beta (14-30 Hz) frequency bands for all pairwise combinations of electrode channels on 10-sec windows. From wPLI and AEC matrices, investigators will calculate:
dPLI will be used to assess feedback dominance index. Investigators will also calculate :
|
5 minutes
|
Stimulation
Time Frame: 30 seconds
|
EEG recording will take place during the 30 seconds of tetanic stimulation, with a 128-channel EEG saline net (measured in microvolts - mV). Investigators will construct functional connectivity networks using the amplitude envelope correlation (AEC), weighted phase lag index (wPLI) and directed phase lag index (dPLI). This will be conducted in delta (0.5-4Hz), theta (4-7 Hz), alpha (8-13 Hz) and beta (14-30 Hz) frequency bands for all pairwise combinations of electrode channels on 10-sec windows. From wPLI and AEC matrices, investigators will calculate:
dPLI will be used to assess feedback dominance index. Investigators will also calculate:
|
30 seconds
|
Post-Stimulation
Time Frame: 5 minutes
|
EEG recording will continue 5 minutes after tetanic stimulation, with a 128-channel EEG saline net (measured in microvolts - mV). Investigators will construct functional connectivity networks using amplitude envelope correlation (AEC), weighted phase lag index (wPLI) and directed phase lag index (dPLI). This will be conducted in delta (0.5-4Hz), theta (4-7 Hz), alpha (8-13 Hz) and beta (14-30 Hz) frequency bands for all pairwise combinations of electrode channels on 10-sec windows. From wPLI and AEC matrices, investigators will calculate:
dPLI will be used to assess feedback dominance index To assess complexity and criticality, investigators will also calculate:
|
5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baseline value of the nocicpetion level index (NOL) - Awake
Time Frame: 1 minute
|
Baseline values of nociception level index (NOL) will be recorded for 1 minute before induction. The NOL is a single dimensionless number, measured by a finger sensory device, which reflects low (0) to high (100) nociception. There is no measurement associated with the NOL since it is a index. |
1 minute
|
Baseline value of the bispectral index (BIS) - Awake
Time Frame: 1 minute
|
Baseline values of the bispectral index (BIS) will be recorded for 1 minute before induction. The BIS is a two-electrode monitor that measures prefrontal EEG activity and assesses intraoperative hypnotic depth. It gives a single number between 0 (total cortical silence) and 100 (fully awake and conscious). There is no measurement associated with the BIS since it is a index. |
1 minute
|
Baseline value of the mean arterial pressure (MAP) - Awake
Time Frame: 1 minute
|
Baseline values of the mean arterial pressure (MAP) will be recorded for 1 minute before induction. The MAP is the average arterial pressure throughout one cardiac cycle, systole, and diastole. It is measured with mmHg. |
1 minute
|
Baseline value of the heart rate (HR) - Awake
Time Frame: 1 minute
|
Baseline values of the heart rate (HR) will be recorded for 1 minute before induction. The HR measures with the number of contractions of the heart per minute (beats per minute, or bpm). |
1 minute
|
Basal value of the nocicpetion level index (NOL) - Pre-stimulation
Time Frame: 1 minute
|
Measurement of the nocicpetion level index (NOL) will start 1 minute before applying noxious stimulus. The NOL is a single dimensionless number, measured by a finger sensory device, which reflects low (0) to high (100) nociception. There is no measurement associated with the NOL since it is a index. |
1 minute
|
Basal value of the bispectral index (BIS) - Pre-stimulation
Time Frame: 1 minute
|
Measurement of the bispectral index (BIS) will start 1 minute before applying noxious stimulus. The BIS is a two-electrode monitor that measures prefrontal EEG activity and assesses intraoperative hypnotic depth. It gives a single number between 0 (total cortical silence) and 100 (fully awake and conscious). There is no measurement associated with the BIS since it is a index. |
1 minute
|
Basal value of the mean arterial pressure (MAP) - Pre-stimulation
Time Frame: 1 minute
|
Measurement of the mean arterial pressure (MAP) will start 1 minute before applying noxious stimulus. The MAP is the average arterial pressure throughout one cardiac cycle, systole, and diastole. It is measured with mmHg. |
1 minute
|
Basal value of the heart rate (HR) - Pre-stimulation
Time Frame: 1 minute
|
Measurement of the heart rate (HR) will start 1 minute before applying noxious stimulus. The HR measures with the number of contractions of the heart per minute (beats per minute, or bpm). |
1 minute
|
Value of nociception level index (NOL) - Stimulation
Time Frame: 30 seconds
|
Measurement of the nociception level index NOL will take place during the 30 seconds of tetanic stimulation. The NOL is a single dimensionless number, measured by a finger sensory device, which reflects low (0) to high (100) nociception. There is no measurement associated with the NOL since it is a index. |
30 seconds
|
Value of bispectral index (BIS) - Stimulation
Time Frame: 30 seconds
|
Measurement of the bispectral index (BIS) will take place during the 30 seconds of tetanic stimulation. The BIS is a two-electrode monitor that measures prefrontal EEG activity and assesses intraoperative hypnotic depth. It gives a single number between 0 (total cortical silence) and 100 (fully awake and conscious). There is no measurement associated with the BIS since it is a index. |
30 seconds
|
Value of the mean arterial pressure (MAP) - Stimulation
Time Frame: 30 seconds
|
Measurement of the mean arterial pressure (MAP) will take place during the 30 seconds of tetanic stimulation. The MAP is the average arterial pressure throughout one cardiac cycle, systole, and diastole. It is measured with mmHg. |
30 seconds
|
Value of the heart rate (HR) - Stimulation
Time Frame: 30 seconds
|
Measurement of the heart rate (HR) will take place during the 30 seconds of tetanic stimulation. The HR measures with the number of contractions of the heart per minute (beats per minute, or bpm). |
30 seconds
|
Value of nociception level index (NOL) - Post-stimulation
Time Frame: 5 minutes
|
Measurement of the nociception level index (NOL) will continue during the 5 minutes after the tetanic stimulation. The NOL is a single dimensionless number, measured by a finger sensory device, which reflects low (0) to high (100) nociception. There is no measurement associated with the NOL since it is a index. |
5 minutes
|
Value of bispectral index (BIS) - Post-stimulation
Time Frame: 5 minutes
|
Measurement of the bispectral index (BIS) will continue during the 5 minutes after the tetanic stimulation. The BIS is a two-electrode monitor that measures prefrontal EEG activity and assesses intraoperative hypnotic depth. It gives a single number between 0 (total cortical silence) and 100 (fully awake and conscious). There is no measurement associated with the BIS since it is a index. |
5 minutes
|
Value of the mean arterial pressure (MAP) - Post-stimulation
Time Frame: 5 minutes
|
Measurement of the mean arterial pressure (MAP) will continue during the 5 minutes after the tetanic stimulation. The MAP is the average arterial pressure throughout one cardiac cycle, systole, and diastole. It is measured with mmHg. |
5 minutes
|
Value of the heart rate (HR) - Post-stimulation
Time Frame: 5 minutes
|
Measurement of the heart rate (HR) will continue during the 5 minutes after the tetanic stimulation. The HR measures with the number of contractions of the heart per minute (beats per minute, or bpm). |
5 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Catherine Duclos, Ph.D, CIUSSS du Nord-de-l'Île-de-Montréal
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MP-12-2022-2984
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia
-
Samsun UniversityCompletedAnesthesia | Regional Anesthesia | Anesthesia ManagementTurkey
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Aligarh Muslim UniversityCompletedAnesthesia | Anesthesia Intubation Complication | Anesthesia; Adverse EffectIndia
-
Universitas Sebelas MaretIndonesia Endowment Fund for EducationNot yet recruitingAnesthesia | Anesthesia; Reaction
-
University of PecsCompleted
-
Hormozgan University of Medical SciencesUnknownAnesthesia | Anesthesia; FunctionalIran, Islamic Republic of
-
University of ChicagoRecruitingAnesthesia | Patient Satisfaction | Anesthesia Risks | Anesthesia Consent | Consent RetentionUnited States
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMNot yet recruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Matthew BorzageRecruitingAnesthesia | Anesthesia; ReactionUnited States
Clinical Trials on EEG-hd (high density electroencephalogram)
-
Dartmouth-Hitchcock Medical CenterEnrolling by invitation
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)Recruiting
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS)CompletedSeizures | Heart ArrestUnited States
-
University of Dublin, Trinity CollegeMotor Neurone Disease Association, UK; Irish Research Council, IE; Research Motor... and other collaboratorsRecruitingALS (Amyotrophic Lateral Sclerosis) | Postpoliomyelitis Syndrome | Spinal Muscular AtrophyIreland
-
University Hospital, BordeauxRecruitingEpilepsy | Parkinson DiseaseFrance
-
University of Wisconsin, MadisonCompleted
-
Baptist Health South FloridaFlorida International UniversityWithdrawnMajor Depression | Repetitive Transcranial Magnetic StimulationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States, China
-
Air Force Military Medical University, ChinaRecruitingPostoperative Cognitive Dysfunction | Aging | EEG With Periodic AbnormalitiesChina
-
Northern Arizona UniversityKidabilities Occupational Therapy ClinicUnknownPediatric ALL | Executive FunctioningUnited States